Bright Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$417K Buy
1,658
+304
+22% +$65.4K 0.17% 49
2026
Q1
$294K Sell
1,354
-16
-1% -$3.55K 0.13% 50
2025
Q4
$313K Sell
1,370
-100
-7% -$22.8K 0.15% 48
2025
Q3
$340K Buy
1,470
+183
+14% +$37.3K 0.17% 45
2025
Q2
$239K Sell
1,287
-20
-2% -$3.72K 0.13% 51
2025
Q1
$274K Buy
1,307
+20
+2% +$3.89K 0.17% 47
2024
Q4
$229K Buy
1,287
+247
+24% +$45.4K 0.14% 49
2024
Q3
$205K Buy
+1,040
New +$194K 0.13% 51

Other funds holding ABBV

Bright Financial Advisors's ABBV Position: Q2 2026 in Review

Bright Financial Advisors increased its AbbVie (ABBV) stake by 22% in Q2 2026, buying an estimated $65.4K and bringing the position to 1,658 shares worth $417K. The position accounts for 0.17% of the portfolio, ranked #49.

Bright Financial Advisors first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bright Financial Advisors held 1,658 shares of AbbVie worth $417K as of Q2 2026.
  • Bright Financial Advisors bought 304 AbbVie shares in Q2 2026, an estimated $65.4K.
  • AbbVie made up 0.17% of Bright Financial Advisors's portfolio in Q2 2026, its #49 holding.
  • Bright Financial Advisors first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bright Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.